GB1218430A - Composition for treatment of pruritis ani - Google Patents

Composition for treatment of pruritis ani

Info

Publication number
GB1218430A
GB1218430A GB3535668A GB3535668A GB1218430A GB 1218430 A GB1218430 A GB 1218430A GB 3535668 A GB3535668 A GB 3535668A GB 3535668 A GB3535668 A GB 3535668A GB 1218430 A GB1218430 A GB 1218430A
Authority
GB
United Kingdom
Prior art keywords
composition
dicarboximide
fungicidal
treatment
bactericidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3535668A
Inventor
Billy F Rankin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Burton Parsons Chemicals Inc
Original Assignee
Burton Parsons Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burton Parsons Chemicals Inc filed Critical Burton Parsons Chemicals Inc
Publication of GB1218430A publication Critical patent/GB1218430A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,218,430. Fungicidal and bactericidal compositions. BURTON PARSONS CHEMICALS Inc. 24 July, 1968 [7 Nov., 1967], No. 35356/ 68. Heading A5B. A fungicidal and bactericidal composition for external application especially for the treatment of pruritis ani consists essentially of N- trichloromethylmercapto-4-cyclohexene-1, 2-dicarboximide (captan) as an active fungicide and bactericide, polyvinylpyrrolidone as a stabilizer for the dicarboximide, and hydrogenated squalene as an active carrier for transepidermal penetration of the composition. The composition may include an ointment base e.g. polyethylene glycol and cetyl alcohol and optionally N-methyl -2-pyrrolidone. The composition may also contain a local anaesthetic e.g. diperodon monohydrate, tetracain or benzocaine; allantoin or salts thereof; oxycholesterin or other cholesterol derivatives hydrocartisone as an anti-inflammatory agent and/or a sequestering agent e.g. ethylenediaminetetraacetic acid di-, tri- or tetra-sodium salt.
GB3535668A 1967-11-07 1968-07-24 Composition for treatment of pruritis ani Expired GB1218430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68111067A 1967-11-07 1967-11-07

Publications (1)

Publication Number Publication Date
GB1218430A true GB1218430A (en) 1971-01-06

Family

ID=24733870

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3535668A Expired GB1218430A (en) 1967-11-07 1968-07-24 Composition for treatment of pruritis ani

Country Status (2)

Country Link
DE (1) DE1800627A1 (en)
GB (1) GB1218430A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009408A2 (en) * 2003-06-25 2005-02-03 Alza Corporation Sustained release dosage forms of anesthetics for pain management
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278330B2 (en) 2002-06-25 2012-10-02 Durect Corporation Short duration depot formulations
US10201496B2 (en) 2002-06-25 2019-02-12 Durect Corporation Short duration depot formulations
US10471001B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US10471002B2 (en) 2002-06-25 2019-11-12 Durect Corporation Short duration depot formulations
US11179326B2 (en) 2002-06-25 2021-11-23 Durect Corporation Short duration depot formulations
WO2005009408A2 (en) * 2003-06-25 2005-02-03 Alza Corporation Sustained release dosage forms of anesthetics for pain management
WO2005009408A3 (en) * 2003-06-25 2006-01-19 Alza Corp Sustained release dosage forms of anesthetics for pain management
EP2067468A1 (en) * 2003-06-25 2009-06-10 ALZA Corporation Sustained release dosage forms of anesthetics for pain management
US11400019B2 (en) 2020-01-13 2022-08-02 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US11771624B2 (en) 2020-01-13 2023-10-03 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Also Published As

Publication number Publication date
DE1800627A1 (en) 1969-08-07

Similar Documents

Publication Publication Date Title
ES8302660A1 (en) Pyridine and pyrazine derivatives, preparation of these compounds, fungicidal agents containing these compounds as active ingredients, and the use of such compounds or agents as fungicides in agriculture and in horticulture.
ATE61050T1 (en) PYRIDAZINAMINES EFFECTIVE AGAINST VIRUSES.
BG50372A3 (en) Fungicidal composition a method of combating fungus
ATE109149T1 (en) 3-PYRROLIDINYLTHIO-1-AZABICYCLO(3.2.0>-HEPT-2-E - 2-CARBONIC ACID COMPOUNDS.
ES485188A1 (en) Diphenylbutyl-piperzinecarboxamides
DE69008366D1 (en) 2-aminopyrimidinone derivatives.
GR3004114T3 (en)
NO941276L (en) Lipophilic, oligosaccharide antibiotic salt preparations
DK166323C (en) GRISEOLIC ACID DERIVATIVES AND PHARMACEUTICAL AGENTS CONTAINING THESE
SE8002322L (en) Means for the treatment of inflammatory bowel diseases
GB2003731A (en) The use of imidazole derivatives as fungicides
ES8604711A1 (en) Pyridine, pyrazine and pyrimidine derivatives and their use as fungicides.
IT1196041B (en) (8S) -8-FLUOROERITROMICINE, THE PROCEDURE FOR THEIR PREPARATION AND FORMULATIONS SUITABLE FOR THE ORAL ADMINISTRATION CONTAINING THE PRODUCTS
GB1218430A (en) Composition for treatment of pruritis ani
JPS6333327A (en) Stabilized phenylephrine liquid agent
ZA846424B (en) Antimicrobial compositions containing benzoic acid derivatives for use as disinfectants,drugs or preservative agents
DK437779A (en) ALFA-AZOLYL-ALFA-PHENYLEDIC ACETIC ACID DERIVATIVES AND GUNGICID CONTAINING SUCH COMPOUNDS
ES8305357A1 (en) 1,3-Dioxolane derivatives, their preparation, fungicidal agents containing those compounds as active agents and use of such compounds or agents in combating fungi in agriculture and in gardening.
GB786753A (en) Improvements in or relating to pyrazole compounds and compositions containing them
AU560193B2 (en) Azolyl-phenoxy-tetrahydrofuran-2-ylidene-methane as fungicidal agents
MX9302832A (en) NEW MEDICINE FOR THE TREATMENT OF ARRHYTHMIA.
DK434789D0 (en) 3-PIPERIDINYL INDAZOLE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PREPARATIONS CONTAINING THE SAME
US3705246A (en) Anti-dermatophytosic composition and method of use
IE34457B1 (en) Sulphinylcyanisothiazoles having a fungicidal activity
JPS635091A (en) Method for preventing coloration